Route 92 Medical Gains EU and MDSAP Certification for its Neurovascular Stroke-Intervention-Focused Product Portfolio
20 nov. 2024 08h00 HE
|
Route 92 Medical, Inc.
Route 92 Medical announces EU and MDSAP certification for its neurovascular stroke-intervention-focused product portfolio.
Route 92 Medical Files Patent Infringement Suit Against Q’Apel Medical
07 oct. 2024 08h33 HE
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical Announces $50 Million Series F Extension Equity Financing
23 sept. 2024 09h00 HE
|
Route 92 Medical, Inc.
Route 92 Medical announces $50 million series F extension equity financing to support its commercial expansion.
Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System
22 juil. 2024 08h00 HE
|
Route 92 Medical, Inc.
Route 92 Medical announces the commercial launch of its FreeClimb 88 catheter system.
Route 92 Medical Announces FDA 510(k) Clearance for FreeClimb 54 Reperfusion System
30 avr. 2024 08h00 HE
|
Route 92 Medical, Inc.
Route 92 Medical announces FDA 510(k) clearance for its FreeClimb 54 reperfusion system, part of its growing portfolio of neurovascular devices.
Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial
21 févr. 2024 08h00 HE
|
Route 92 Medical, Inc.
Route 92 Medical announces completion of enrollment in the SUMMIT MAX clinical trial studying their .088" HiPoint Reperfusion Catheter.
Route 92 Medical Announces the 100th Patent for its Neurovascular Intervention Portfolio
08 janv. 2024 09h00 HE
|
Route 92 Medical, Inc.
Route 92 Medical announces the receipt of its 100th patent for its rapidly growing portfolio of neuromuscular intervention products.
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market
16 nov. 2023 09h00 HE
|
Route 92 Medical, Inc.
Route 92 Medical raises over $31 million in oversubscribed Series F equity financing to accelerate its commercialization.
Route 92 Medical Announces Impressive Clinical Results for its Tenzing® Technology.
14 nov. 2023 09h00 HE
|
Route 92 Medical, Inc.
Multicenter clinical study results published in Stroke: Vascular and Interventional Neurology show benefits of Route 92 Medical's Tenzing technology.
Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
18 sept. 2023 09h00 HE
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...